A. The "prescription drug importation advisory committee" is created as an interagency advisory committee of the department. The committee consists of:
(1) the secretary of health, who shall serve as the chair of the committee;
(2) the executive director of the board of pharmacy;
(3) the superintendent of insurance;
(4) the secretary of human services; and
(5) the secretary of general services.
B. Members may appoint designees.
C. The committee shall advise the department in developing and implementing the program. The committee shall consult with interested stakeholders and appropriate federal officials as necessary in shaping its advice to the department. The department shall hold a public hearing on the proposed program prior to submitting the program for federal approval.
History: Laws 2020, ch. 45, § 3.
ANNOTATIONSEmergency clauses. — Laws 2020, ch. 45, § 11 contained an emergency clause and was approved March 4, 2020.